ANOOP & SNIGDHA LTD

Company number 13937301 ·

Dissolved

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ANOOP & SNIGDHA LTD - Analysis Report

Company Number: 13937301

Analysis Date: 2025-07-29 19:01 UTC

Financial Health Assessment for ANOOP & SNIGDHA LTD


1. Financial Health Score: B+

Explanation:
ANOOP & SNIGDHA LTD demonstrates a robust improvement in financial health over the past two years, showing a significant turnaround from negative net current assets to a strong positive position. The company maintains a healthy cash buffer relative to liabilities and has built solid equity. The "B+" score reflects a company in good financial shape but still in early operational years, with some opportunities to further strengthen its financial base and operational scalability.


2. Key Vital Signs

Metric 2024 Value Interpretation
Fixed Assets £1,287 Modest investment in long-term assets, typical for a micro-entity.
Current Assets £76,607 Strong liquidity position, indicates healthy cash and receivables.
Current Liabilities £27,310 Manageable short-term obligations.
Net Current Assets £49,297 Positive working capital; "healthy cash flow" symptom.
Net Assets (Equity) £50,584 Solid equity base reflecting retained earnings or capital injection.
Employee Count 2 Small workforce, typical of a micro-entity.

Trend Analysis:

  • From 2023 to 2024, current assets increased by over 700%, while current liabilities more than doubled but remained well covered by assets.
  • Net current assets improved from a negative £2,646 to a positive £49,297, a strong sign of financial healing.
  • Shareholders’ funds mirrored this improvement, indicating capital injection or profitability.

3. Diagnosis

ANOOP & SNIGDHA LTD presents clear signs of recovery from initial financial "symptoms of distress" observed in 2023, when current liabilities exceeded current assets, indicating potential liquidity risk or short-term cash flow issues. The dramatic increase in current assets in 2024 suggests either a significant capital injection, improved revenue collections, or enhanced cash reserves.

The micro-entity balance sheet shows prudent management with limited fixed asset investment, which is common in service-oriented businesses in the healthcare sector (SIC 86900: Other human health activities). The company’s positive working capital and net assets indicate it can comfortably meet short-term obligations and has a cushion to absorb shocks.

However, given the company’s infancy (incorporated 2022) and small size, it remains vulnerable to operational risks and market fluctuations. The director’s dual control and significant voting rights concentrate decision-making but also indicate strong leadership involvement.


4. Recommendations

  • Maintain Strong Liquidity: Continue monitoring working capital closely to sustain "healthy cash flow." Avoid overextension of credit and manage payables carefully.
  • Build Reserves: With positive net assets, begin building retained earnings to buffer future uncertainties. Consider modest reinvestment in fixed assets if it supports business growth.
  • Financial Planning: Develop a cash flow forecast to anticipate funding needs and prevent liquidity crunches that could cause "symptoms of distress."
  • Operational Scaling: With only 2 employees, assess workload capacity and scalability plans. Consider recruitment or outsourcing to support growth without excessive cost.
  • Governance: Ensure robust internal controls and clear financial reporting given the small management team to avoid risks associated with concentrated decision-making.
  • Compliance: Keep up-to-date with filing deadlines and regulatory obligations to avoid penalties and maintain creditor confidence.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.